Clinical relevance of PD‐L1 expression in gallbladder cancer: a potential target for therapy

A Neyaz, N Husain, S Kumari, S Gupta… - …, 2018 - Wiley Online Library
Aims Programmed death‐ligand 1 (PD‐L1), a potential target for immune checkpoint
inhibitors in various solid neoplasms, has been studied in very few cases of Gall Bladder …
被引用次数：40 相关文章

[引用][C] Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy

A Neyaz, N Husain, S Kumari, S Gupta, S Shukla… - Histopathology, 2018 - cir.nii.ac.jp
Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy

A Neyaz, N Husain, S Kumari, S Gupta… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Aims Programmed death-ligand 1 (PD-L1), a potential target for immune checkpoint
inhibitors in various solid neoplasms, has been studied in very few cases of Gall Bladder …

Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy.

A Neyaz, N Husain, S Kumari, S Gupta, S Shukla… - …, 2018 - europepmc.org
Aims Programmed death-ligand 1 (PD-L1), a potential target for immune checkpoint
inhibitors in various solid neoplasms, has been studied in very few cases of Gall Bladder …

Clinical relevance of PD‐L1 expression in gallbladder cancer: a potential target for therapy.

A Neyaz, N Husain, S Kumari, S Gupta… - …, 2018 - search.ebscohost.com
Abstract Aims: Programmed death‐ligand 1 (PD‐L1), a potential target for immune
checkpoint inhibitors in various solid neoplasms, has been studied in very few cases of Gall …